中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 6
Jun.  2013
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2013  >  29(6): 404-406+410

Clinical classification of hepatolithiasis and choice of surgical strategy

  • Department of Hepatobiliary Surgery, Chinese PLA General Hospital

Research funding:

 

  • Published Date: 2013-06-20
    Abstract

  • Surgery is the first-line treatment for hepatolithiasis, but the choice of surgical strategy does not meet the criteria in many medical institutions in China, resulting in high residual stone rate and recurrence rate among patients with hepatolithiasis after surgery.We think clinical classification of hepatolithiasis is great clinical significance for the choice of surgical strategy.This paper reviews the indications for hepatectomy, choledochoenterostomy, bile duct exploration and stone extraction, and liver transplantation in hepatolithiasis according to our clinical experiences.In addition, this paper gives a brief introduction to the surgical skills of hepatectomy and innovative technology of anatomical hepatectomy for treating hepatolithiasis in Chinese PLA General Hospital.

     

    • FullText(HTML)
    • References(25)
  • [1]Chen XG, Liu JQ, Peng MH, et al.Intrahepatic cholelithiasis inGuangxi, an analysis of 8585 cases[J].Chin J Gen Surg, 2002, 17 (2) :99-101. (in Chinese) 陈希纲, 刘家奇, 彭民浩, 等.胆石病临床流行病学调查-附8585例分析[J].中华普通外科杂志, 2002, 17 (2) :99-101.
    [2]Tazuma S.Gallstone disease:Epidemiology, pathogenesis, andclassification of biliary stones (common bile duct and intrahepatic) [J].Best Pract Res Clin Gastroenterol, 2006, 20 (6) :1075-1083.
    [3]Huang ZQ.Progress in hepatectomy for hepatolithiasis[J].Chin J CurrAdv Gen Surg, 2009, 12 (1) :1-2. (in Chinese) 黄志强.肝内胆管结石肝切除术的演变[J].中国现代普通外科进展, 2009, 12 (1) :1-2.
    [4]Jiang ZY, Han TQ, Zhang AD.Pathogenesis of cholesterol gallstonedisease[J].Chin J Gastro, 2010, 18 (12) :1191-1195. (inChinese) 蒋兆彦, 韩天权, 张圣道.胆固醇结石病的发生机制[J].世界华人消化杂志, 2010, 18 (12) :1191-1195.
    [5] Li FY, Cheng NS, Mao H, et al.Significance of controlling chronicproliferative cholangitis in the treatment of hepatolithiasis[J].World J Surg, 2009, 33 (10) :2155-2160.
    [6]Nakayama F.Intrahepatic calculi:A special problem in East Asia[J].World J Surg, 1982, 6 (6) :802-804.
    [7]Biliary Surgery Group of Surgery Branch of Chinese Medical Associa-tion.Guildline for management and diagnosis for hepatolithiasis[J].Chin J Dig Surg, 2007, 6 (2) :156-160. (in Chinese) 中华医学会外科学分会胆道外科学组.肝胆管结石病诊断治疗指南[J].中华消化外科杂志, 2007, 6 (2) :156-160.
    [8]Kong J, Wu SD.Comprehensive review of strategies for diagnosisand treatment of hepatolithiasis[J].J Clin Hepatol, 2013, 29 (3) :163-165. (in Chinese) 孔静, 吴硕东.肝内外胆管结石的综合诊断与治疗[J].临床肝胆病杂志, 2013, 29 (3) :163-165.
    [9]Huang CC.Partial resection of the liver in treatment of intrahepaticstones[J].Chin Med J, 1959, 79 (7) :40-45.
    [10] Huang ZQ, Ma X.Partial resection of the liver in treatment of intra-hepatic stones[J].Chin J Surg, 1958, 6 (1) :1221-1224. (inChinese) 黄志强, 马宵.肝部分切除术治疗肝内胆管结石[J].中华外科杂志, 1958, 6 (1) :1221-1224.
    [11]Uchiyama K, Kawai M, Ueno M, et al.Reducing residual and re-current stones by hepatectomy for hepatolithiasis[J].J GastrointestSurg, 2007, 11 (5) :626-630.
    [12]Lee TY, Chen YL, Chang HC, et al.Outcomes of hepatectomy forhepatolithiasis[J].World J Surg, 2007, 31 (3) :479-482.
    [13]Chen DW, Tung-Ping Poon R, Liu CL, et al.Immediate and long-term outcomes of hepatectomy for hepatolithiasis[J].Surgery, 2004, 135 (4) :386-393.
    [14]Hasegawa K, Kokudo N, Imamura H, et al.Prognostic impact ofanatomic resection for hepatocellular carcinoma[J].Ann Surg, 2005, 242 (2) :252-259.
    [15]Jarufe N, Figueroa E, Muoz C, et al.Anatomic hepatectomy as adefinitive treatment for hepatolithiasis:a cohort study[J].HPB (Oxford) , 2012, 14 (9) :604-610.
    [16]Jiang H, Wu H, Xu YL, et al.An appraisal of anatomical and lim-ited hepatectomy for regional hepatolithiasis[J].HPB Surg, 2010, 2010:91625.
    [17]Cai SW, Lu WP, Yang SZ, et al.Application of persistent methyl-ene blue dyeing method for anatomic hepatotectomy of hepatocehularcarcinoma with bile duct tumor thrombi[J].Chin J Surg, 2012, 50 (6) :502-504. (in Chinese) 蔡守旺, 吕文平, 杨世忠, 等.持久亚甲蓝染色法在肝细胞癌合并胆管癌栓解剖性肝切除术中的应用[J].中华外科杂志, 2012, 50 (6) :502-504.
    [18]Cai SW, Xie Y, Yang SZ, et al.Application of lasting methyleneblue staining in precise hepatectomy[J].Chin J Dig Surg, 2010, 10 (1) :28-30. (in Chinese) 蔡守旺, 谢于, 杨世忠, 等.持久美蓝染色法在精准肝切除中的应用价值[J].中华消化外科杂志, 2010, 10 (1) :28-30.
    [19] Dong JH, Zhen SS, Chen XP, et al.Consensus on evaluation ofHepatic functional reserve before hepatectomy[J].Chin J DigSurg, 2011, 10 (1) :20-25. (in Chinese) 董家鸿, 郑树森, 陈孝平, 等.肝切除术前肝脏储备功能评估的专家共识 (2011版) [J].中华消化外科杂志, 2011, 10 (1) :20-25.
    [20]Dong J, Lau WY, Lu W, et al.Caudate lobe-sparing subtotalhepatectomy for primary hepatolithiasis[J].Br J Surg, 2012, 99 (10) :1423-1428.
    [21]Wan T, Zhou NX.Preserve sphincter of Oddi function in operationfor hepatolithiasis[J].Chin J Pract Surg, 2004, 24 (2) :119-120. (in Chinese) 万涛, 周宁新.保留Oddi括约肌在肝胆管结石病外科治疗中的意义[J].中国实用外科杂志, 2004, 24 (2) :119-120.
    [22]Yuasa N, Miyata K, Kobayashi Y, et al.Mucosal dysplasia in thebile duct after choledochoduodenostomy:a case report[J].Hepato-gastroenterology, 2000, 47 (35) :1238-1240.
    [23]Kuo K, Ker CG, Sheen PC, et al.Changes of bile duct mucosa af-ter choledochoduodenostomy in rats[J].Eur Surg Res, 1996, 28 (1) :63-69.
    [24] Dong JH, Huang ZQ.Precise liver resection—new concept of liversurgery in 21st century[J].Chin J Surg, 2009, 47 (21) :1601-1605. (in Chinese) 董家鸿, 黄志强.精准肝切除———21世纪肝脏外科新理念[J].中华外科杂志, 2009, 47 (21) :1601-1605.
    [25]Lu WP, Huang ZQ, Dong JH.Biliary injury in laparoscopic chole-cystectomy[J].Chin J Surg, 2008, 46 (6) :463-464. (in Chi-nese) 吕文平, 黄志强, 董家鸿.腹腔镜胆囊切除与医源性胆管损伤[J].中华外科杂志, 2008, 46 (6) :463-464.
    • Relative Articles

  • Relative Articles

    [1]Lanjing WANG, Xin YAO, Jianping QIN, Shanhong TANG. TIPS for treatment of refractory ascites in cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2606-2610. doi: 10.3969/j.issn.1001-5256.2022.11.034
    [2]Lei WANG. Integrated traditional Chinese and Western medicine diagnosis and treatment of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2022, 38(9): 1956-1961. doi: 10.3969/j.issn.1001-5256.2022.09.002
    [3]Yu TIAN, Jia HONG, Bingqiong WANG, Hong YOU. Current status and prospects of long-term albumin treatment in patients with cirrhotic ascites[J]. Journal of Clinical Hepatology, 2021, 37(1): 173-175. doi: 10.3969/j.issn.1001-5256.2021.01.037
    [5]Chen Yu, Zhou Li. Research advances in treatment of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2016, 32(6): 1069-1074. doi: 10.3969/j.issn.1001-5256.2016.06.009
    [6]Yu Yuan, Zhang JianLiang, Lu YunFei, Chen XiaoRong. Application of external treatment of traditional Chinese medicine in cirrhotic ascites[J]. Journal of Clinical Hepatology, 2016, 32(4): 781-784. doi: 10.3969/j.issn.1001-5256.2016.04.040
    [7]Fan ZhiDong, You JinLi. Diagnosis and treatment procedure for intractable liver ascites[J]. Journal of Clinical Hepatology, 2015, 31(3): 472-474. doi: 10.3969/j.issn.1001-5256.2015.03.039
    [8]Zhong HuaPing, Zhou Zhi, Liao GuiLan. Analysis of early warning indicators of tuberculous peritonitis in patients with cirrhotic ascites[J]. Journal of Clinical Hepatology, 2014, 30(4): 357-359. doi: 10.3969/j.issn.1001-5256.2014.04.017
    [9]Xie WeiFen, Ceng Xin. Controversial problems in management of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2014, 30(7): 601-603. doi: 10.3969/j.issn.1001-5256.2014.07.006
    [10]Zhu Peng, Wang YuMing. Introduction to the revised American Association for the Study of Liver Diseases practice guideline management of adult patients with ascites due to cirrhosis 2012[J]. Journal of Clinical Hepatology, 2013, 29(9): 645-646. doi: 10.3969/j.issn.1001-5256.2013.09.002
    [11]Liu ChengHai, Xing Feng. The potential benefit managing ascites due to cirrhosis using an integrative medicine approach[J]. Journal of Clinical Hepatology, 2013, 29(4): 253-256.
    [12]Wu HaiQing, Wang Hui. Diagnosis and treatment of spontaneous bacterial peritonitis in patients with liver ascites[J]. Journal of Clinical Hepatology, 2012, 28(9): 651-653.
    [13]Zeng Zhen, Xing Feng, Zhou AiMin, Tao YanYan, Liu ChengHai. Effect of Xiaozhang Tie on cirrhotic ascites and peritoneal vascular permeability in mice[J]. Journal of Clinical Hepatology, 2012, 28(9): 689-694.
    [14]Liu JianJun, Li Nan, Zhi Hong, Wu XiaoYing. Current clinical perspectives and implications of cirrhotic ascites in China[J]. Journal of Clinical Hepatology, 2012, 28(9): 701-703.
    [15]Shi HaiDong. Clinical observation of alprostadil injection in the treatment of liver cirrhosis with jaundice[J]. Journal of Clinical Hepatology, 2011, 27(9): 962-964.
    [16]Yuan ShanShan, Han GuoHong, Bo Ming, He ChuangYe, Yin ZhanXin, Wang JianHong, Qi XingShun, Yang ZhiPing, Zhang Wei. Prognostic factors in the prediction of survival following TIPS for cirrhosis and refractory ascites[J]. Journal of Clinical Hepatology, 2011, 27(5): 525-527.
    [17]Qiu Ling, Hu YuLin. Recent status and prospect of ascites treatment in cirrhosis patients[J]. Journal of Clinical Hepatology, 2010, 26(6): 663-665.
    [18]Zhan GuoQing, Tan HuaBing, Li RuGui, Du WeiXing, Li Gang, Zhu Lin. The efficacy of mannital combined with dopamine for the treatment of refractory ascites in cirrhosis[J]. Journal of Clinical Hepatology, 2009, 25(6): 424-426.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 3.4 %FULLTEXT: 3.4 %META: 87.9 %META: 87.9 %PDF: 8.8 %PDF: 8.8 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 3.4 %其他: 3.4 %China: 0.8 %China: 0.8 %India: 0.6 %India: 0.6 %Taiwan, China: 0.3 %Taiwan, China: 0.3 %[]: 0.3 %[]: 0.3 %上海: 2.0 %上海: 2.0 %北京: 6.5 %北京: 6.5 %南京: 0.3 %南京: 0.3 %南宁: 0.3 %南宁: 0.3 %台州: 0.3 %台州: 0.3 %台湾省: 0.3 %台湾省: 0.3 %吉林: 7.3 %吉林: 7.3 %宁波: 0.3 %宁波: 0.3 %密蘇里城: 0.3 %密蘇里城: 0.3 %广州: 0.3 %广州: 0.3 %张家口: 4.8 %张家口: 4.8 %昆明: 1.1 %昆明: 1.1 %杭州: 1.4 %杭州: 1.4 %武汉: 0.3 %武汉: 0.3 %沈阳: 0.3 %沈阳: 0.3 %济南: 0.3 %济南: 0.3 %深圳: 0.3 %深圳: 0.3 %湖州: 1.1 %湖州: 1.1 %漯河: 0.3 %漯河: 0.3 %烟台: 0.3 %烟台: 0.3 %石家庄: 0.6 %石家庄: 0.6 %芒廷维尤: 30.8 %芒廷维尤: 30.8 %芝加哥: 0.3 %芝加哥: 0.3 %莫斯科: 1.7 %莫斯科: 1.7 %衢州: 1.1 %衢州: 1.1 %西宁: 29.7 %西宁: 29.7 %金华: 1.1 %金华: 1.1 %长春: 1.4 %长春: 1.4 %其他ChinaIndiaTaiwan, China[]上海北京南京南宁台州台湾省吉林宁波密蘇里城广州张家口昆明杭州武汉沈阳济南深圳湖州漯河烟台石家庄芒廷维尤芝加哥莫斯科衢州西宁金华长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3102) PDF downloads(692) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2530]YesterdayPV[4969]TodayIP[415]TodayPV[621]Online[59]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return